Intellectual property lawfromPatently-O2 weeks agoThe Federal Circuit's Rigid Approach to Secondary ConsiderationsPurdue Pharma challenges the Federal Circuit's stringent 'nexus' requirement for evaluating patent non-obviousness in a Supreme Court appeal.
Intellectual property lawfrompatentlyo.com2 months agoThe OxyContin Conundrum: Can a Creator of Crisis Patent Its Solution?Purdue Pharma's reorganization plan aims to address the opioid crisis while navigating ethical challenges surrounding their past misconduct.
FundraisingfromFast Company2 months agoPurdue Pharma files a new $7 billion bankruptcy plan to settle opioid lawsuitsPurdue Pharma seeks bankruptcy judge's approval for a revised opioid crisis settlement plan involving the Sackler family.The Sacklers agree to relinquish ownership and contribute $7 billion over 15 years.
Businessfromwww.theguardian.com5 months agoMcKinsey to pay $650m to resolve US investigation into opioid crisis roleMcKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.
BusinessfromBoston.com3 months agoMore than $100 million expected in Mass. from $7.4 billion settlement with Purdue Pharma, SacklersPurdue Pharma and the Sackler family have settled lawsuits for $7.4 billion over the opioid crisis, marking a significant judicial outcome.
Intellectual property lawfrompatentlyo.com2 months agoThe OxyContin Conundrum: Can a Creator of Crisis Patent Its Solution?Purdue Pharma's reorganization plan aims to address the opioid crisis while navigating ethical challenges surrounding their past misconduct.
FundraisingfromFast Company2 months agoPurdue Pharma files a new $7 billion bankruptcy plan to settle opioid lawsuitsPurdue Pharma seeks bankruptcy judge's approval for a revised opioid crisis settlement plan involving the Sackler family.The Sacklers agree to relinquish ownership and contribute $7 billion over 15 years.
Businessfromwww.theguardian.com5 months agoMcKinsey to pay $650m to resolve US investigation into opioid crisis roleMcKinsey acknowledges wrongdoing and pays $650 million related to the opioid epidemic settlement over five years.
BusinessfromBoston.com3 months agoMore than $100 million expected in Mass. from $7.4 billion settlement with Purdue Pharma, SacklersPurdue Pharma and the Sackler family have settled lawsuits for $7.4 billion over the opioid crisis, marking a significant judicial outcome.